0001140361-19-007494.txt : 20190424 0001140361-19-007494.hdr.sgml : 20190424 20190424060304 ACCESSION NUMBER: 0001140361-19-007494 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190424 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20190424 DATE AS OF CHANGE: 20190424 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NU SKIN ENTERPRISES INC CENTRAL INDEX KEY: 0001021561 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 870565309 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12421 FILM NUMBER: 19762528 BUSINESS ADDRESS: STREET 1: 75 WEST CENTER ST STREET 2: ATTN: GREGORY BELLISTON CITY: PROVO STATE: UT ZIP: 84601 BUSINESS PHONE: 801-345-1000 MAIL ADDRESS: STREET 1: 75 WEST CENTER ST STREET 2: ATTN: GREGORY BELLISTON CITY: PROVO STATE: UT ZIP: 84601 FORMER COMPANY: FORMER CONFORMED NAME: NU SKIN ASIA PACIFIC INC DATE OF NAME CHANGE: 19960919 8-K 1 form8k.htm FORM 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 
April 24, 2019
 
 
Date of Report (Date of earliest event reported)
 

 
NU SKIN ENTERPRISES, INC.
 
 
(Exact name of registrant as specified in its charter)
 

Delaware
 
001-12421
 
87-0565309
(State or other jurisdiction of incorporation)
 
(Commission File Number)
 
(IRS Employer Identification Number)

 
75 West Center Street
Provo, Utah 84601
 
 
(Address of principal executive offices and zip code)
 

 
(801) 345-1000
 
 
(Registrant’s telephone number, including area code)
 

 
N/A
 
 
(Former name or former address, if changed since last report)
 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 7.01
Regulation FD Disclosure.

An electronic copy of the Letter to Shareholders, excerpted from the Nu Skin Enterprises, Inc. 2018 Annual Report to Shareholders, is attached hereto as Exhibit 99.1. The 2018 Annual Report to Shareholders will be first sent or given to our shareholders on or about April 25, 2019. A complete copy of the 2018 Annual Report to Shareholders can be obtained on the Investor Relations portion of our website, ir.nuskin.com, or by contacting our Investor Relations Department, telephone: 801-345-1000, e-mail: investorrelations@nuskin.com, address: 75 West Center Street, Provo, Utah 84601.

The information furnished pursuant to this Item 7.01 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act except as shall be expressly set forth by specific reference in such filing.

Item 9.01
Financial Statements and Exhibits.

(d) Exhibit.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
NU SKIN ENTERPRISES, INC.
 
(Registrant)
   
 
/s/ Mark H. Lawrence
 
 
Mark H. Lawrence
 
Chief Financial Officer
   
Date:  April 24, 2019
 



EX-99.1 2 ex99_1.htm LETTER TO SHAREHOLDERS
Exhibit 99.1

DEAR SHAREHOLDER,

Two years ago, when I became CEO, our management team put in place a dynamic strategy to grow our Nu Skin business focused on driving customer growth through engaging digital platforms, enabling products, and empowering programs for our global sales force.

As we look back on 2018, I am encouraged with the execution of our strategy and the momentum it has generated within our business. We made healthy strides with double-digit revenue growth and steady expansion of both our customers and sales leaders. Perhaps most importantly, we learned valuable lessons that will make us better and stronger as we pursue our ultimate vision of becoming the world’s leading business opportunity platform.

Our 2018 success was highlighted by:


18% revenue growth ($2.68 billion)

16% customer growth (1.24 million)

16% increase in sales leaders from Q1 2018 (73,400)

Growth in nearly every reporting segment

As we shift our attention forward, we look to build on this momentum in 2019. In order to achieve our goals, we plan to focus on three key growth drivers:

1) Invest to accelerate customer growth—We remain committed to driving global customer growth. Today, our customer base exceeds 1.2 million active purchasers of our product, spread across nearly 50 global markets. We are further strengthening our focus on the customer throughout the organization and continue to invest in technology and innovation to better support our current and future customer growth.

2) Invest to drive sales leader expansion and productivity—Our most important asset is our people, which includes our dedicated and talented sales leaders around the world. Our success depends upon increasing our global sales force, helping them be successful, and improving their productivity. We are advancing this effort by actively investing in digital tools and programs to better support them in building their business.

3) Leverage our resources and capabilities—We have recently invested in several partner companies to drive growth and efficiencies in our core business. These companies also have significant opportunities to grow and innovate within their respective industries and provide competitive advantages to our core business. We see substantial opportunities to leverage our resources and capabilities to drive growth in these partner companies.

Our core Nu Skin business holds tremendous potential, and we will continue to focus on our 3P Growth Strategy, which we believe will provide the fuel necessary to move our business forward.

Platforms—We are making significant investments in our digital platform to leverage social sharing, which empowers our sales leaders to attract, acquire, and retain customers through their use of social media and technology. In addition, we are making some significant changes to become a more customer-obsessed, digitally enabled company by transitioning our technology core to the cloud. We anticipate this transition will expand our scale, increase our speed and capacity, and provide improved flexibility to better serve our customers.


Products—Our most recent product innovation, ageLOC LumiSpa, has been instrumental in accelerating customer acquisition. During the year, we sold more than $250 million worth of LumiSpa devices and accompanying consumables. To increase the footprint of this unique facial cleansing and treatment device, we are introducing an innovative attachment for use on the delicate skin around the eyes called LumiSpa Accent. We anticipate LumiSpa will continue to be a growth driver in 2019 and beyond. We will also be introducing new products designed to be promoted via social sharing as well as rolling out powerful product restages and enhancements throughout the year.

Programs—We continue to roll out Velocity, our compensation program enhancement, and will have it in all markets except Mainland China this year. This program focuses on accelerating rewards to our sales leaders on a daily, weekly, and monthly basis. It also provides increased rewards for sharing our products and greater flexibility to appeal to a broader demographic.

We have great confidence in our recently acquired manufacturers that accelerate the speed to market for many of Nu Skin’s products. These partners augment our ability to innovate and improve our core business manufacturing cost efficiencies. In 2018, our manufacturing partners contributed approximately $90 million to our top-line results, and we anticipate continued growth this year.

As discussed at our 2019 Investor Day, we have made great strides in developing our indoor growing technology. This controlled environment agriculture (CEA) technology is intended to enhance our ability to provide customers with pure, sustainable, and effective ingredients—with full sourcing transparency—while providing a competitive advantage in our product development. We believe this technology also has great opportunities for application outside of our core business, and we are currently in the process of testing these applications.

In conclusion, we are excited for the future. We are focused on empowering growth in our business and generating strong financial results. We will continue to drive sustainable business practices and live up to our mission of being a force for good in the world, which we believe will generate competitive and business advantages for long-term success.

/s/ Ritch Wood

RITCH WOOD
Chief Executive Officer


FORWARD-LOOKING STATEMENTS: This annual report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that represent the company’s current expectations and beliefs. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws and include, but are not limited to, statements of management’s expectations regarding the company’s performance, growth, customers and sales force, products and product introductions, strategies, initiatives, investments, areas of focus, and the performance and potential of the company’s manufacturing and CEA partners; statements of belief; and statements of assumptions underlying any of the foregoing. In some cases, you can identify these statements by forward-looking words such as “believe,” “expect,” “anticipate,” “become,” “potential,” “intend,” “plan,” “will,” “would,” “could,” “may,” “might,” the negative of these words and other similar words. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. We caution and advise readers that these statements are based on assumptions that may not be realized and involve risks and uncertainties that could cause actual results to differ materially from the expectations and beliefs contained herein. For a summary of certain risks related to our business, see the company’s Annual Report on Form 10-K, filed on February 14, 2019, and other documents filed by the company with the Securities and Exchange Commission.